Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Neal

Showing results (21-30 of 302) with videos related to

Pageof 31
Sort By:
BJU International|June 25, 2014
Incidence of needle-tract seeding following prostate biopsy for suspected cancer: a review of the literatureDimitrios Volanis, David E Neal, Anne Y Warren, et al.
Nucleic Acids Research|January 11, 2005
Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylationLuke Gaughan, Ian R Logan, David E Neal, et al.
Nucleic Acids Research|September 1, 2021
Correction to 'Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation'Luke Gaughan, Ian R Logan, David E Neal, et al.
The Journal of Biological Chemistry|September 6, 2003
The scaffolding protein RACK1 interacts with androgen receptor and promotes cross-talk through a protein kinase C signaling pathwayAnastasia C Rigas, Daniel M Ozanne, David E Neal, et al.
Oncogene|July 26, 2002
Regulation of FGF8 expression by the androgen receptor in human prostate cancerVincent J Gnanapragasam, Craig N Robson, David E Neal, et al.
Endocrine-Related Cancer|January 10, 2014
Estrogen receptor beta in prostate cancer: friend or foe?Adam W Nelson, Wayne D Tilley, David E Neal, et al.
Oncotarget|July 9, 2014
Transcriptomic analysis reveals inhibition of androgen receptor activity by AMPK in prostate cancer cellsSarah Jurmeister, Antonio Ramos-Montoya, David E Neal, et al.
BMJ (Clinical Research Ed.)|June 28, 2003
Ethics of clinical trials from bayesian perspective: randomisation to clinical trials may solve dilemma of treatment choice in prostate cancerFreddie C Hamdy, Jenny L Donovan, J Athene Lane, et al.
Lancet (London, England)|August 12, 2009
Screening for prostate cancer remains controversialDavid E Neal, Jenny L Donovan, Richard M Martin, et al.
BJU International|September 29, 2011
The role of surgery in high-risk localised prostate cancerVincent J Gnanapragasam, Malcolm D Mason, Greg L Shaw, et al.
Pageof 31

Showing results (21-30 of 302) with videos related to

Sort By:
Pageof 31
BJU International|June 25, 2014
Incidence of needle-tract seeding following prostate biopsy for suspected cancer: a review of the literatureDimitrios Volanis, David E Neal, Anne Y Warren, et al.
Nucleic Acids Research|January 11, 2005
Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylationLuke Gaughan, Ian R Logan, David E Neal, et al.
Nucleic Acids Research|September 1, 2021
Correction to 'Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation'Luke Gaughan, Ian R Logan, David E Neal, et al.
The Journal of Biological Chemistry|September 6, 2003
The scaffolding protein RACK1 interacts with androgen receptor and promotes cross-talk through a protein kinase C signaling pathwayAnastasia C Rigas, Daniel M Ozanne, David E Neal, et al.
Oncogene|July 26, 2002
Regulation of FGF8 expression by the androgen receptor in human prostate cancerVincent J Gnanapragasam, Craig N Robson, David E Neal, et al.
Endocrine-Related Cancer|January 10, 2014
Estrogen receptor beta in prostate cancer: friend or foe?Adam W Nelson, Wayne D Tilley, David E Neal, et al.
Oncotarget|July 9, 2014
Transcriptomic analysis reveals inhibition of androgen receptor activity by AMPK in prostate cancer cellsSarah Jurmeister, Antonio Ramos-Montoya, David E Neal, et al.
BMJ (Clinical Research Ed.)|June 28, 2003
Ethics of clinical trials from bayesian perspective: randomisation to clinical trials may solve dilemma of treatment choice in prostate cancerFreddie C Hamdy, Jenny L Donovan, J Athene Lane, et al.
Lancet (London, England)|August 12, 2009
Screening for prostate cancer remains controversialDavid E Neal, Jenny L Donovan, Richard M Martin, et al.
BJU International|September 29, 2011
The role of surgery in high-risk localised prostate cancerVincent J Gnanapragasam, Malcolm D Mason, Greg L Shaw, et al.
Pageof 31